콘텐츠로 건너뛰기
주식/증권 ➡️ 중립

Bristol Myers Stock Rises. Why the Drugmaker Is Lifting Its Earnings Guidance.

요약

Bristol Myers Squibb faces declining revenue in its legacy drug portfolio, but new products like Opdivo are offsetting the drop.